Coronavirus Disease 2019, or COVID-19, is a novel respiratory disease that has been characterized as a pandemic by the World Health Organization. Advanta Genetics has developed a new diagnostic test for the virus that causes COVID-19 (referred to as SARS-CoV-2). Rapid identification of individuals with this virus is important in addressing this escalating public health issue.
For more information about our prepared viral transport media: CDC Posts New Standard Operating Procedure for Creating Viral Transport Media
**Note: Transport tubes must be stored in refrigerator at all timesIf you require a sample collection kit, please contact us at advanta@aalabs.com.
Download and complete the appropriate Test Requisition Form (TRF) Download Order Form
Download a completed sample Covid19 Positive report Download Sample Positive Report
FOR BATCH ORDERS: Download and complete the appropriate CSV file Download CSV Form
Specimen Type: Lower respiratory tract
Sources: Sputum, Oropharyngeal swabs, Nasopharyngeal swabs
Advanta Analytical Laboratories- Licensing & Regulatory Accreditation | |
---|---|
Licensing & Regulatory | Number |
CAP Certification Certificate | 8863194 |
CAP Accreditation Letter | 8863194 |
CAP List of Deficiencies | 8863194 |
CLIA Accredited | 45D2063134 |
DEA Certificate | RA0543125 |
State of Florida | 108217 |
State of Maryland | 2391 |
State of Pennsylvania | 34867 |
Pennsylvania License Letter | 34867 |
Notice of Privacy Practices |